Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends


Award-winning journal providing in-depth analysis on today’s most important topics

Out of Balance: Workforce Gender Disparities and What They Mean for Workers’ Comp

Adverse effects of the pandemic on women, the workforce, and workers' comp
Winter 2021/2022

A Brighter Tomorrow? Applying Pandemic Lessons Today

A message from the Chief Executive Officer
Summer 2021

Home Alone: The Mental Health Impact of Working from Home

Extensive isolation and unique stressors may leave remote workers stressed
Summer 2021

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

COVID-19 Pill Approval and More Updates

Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.
Dec 2021

The Long Haul: Chronic Health Complications of COVID-19

Those previously infected by the virus may face long-term health complications.
Dec 2021

Can Virtual Reality Help with Pain Management?

A new study found that VR sessions averaged a 40% reduction in pain and decreased opioid use.
Dec 2021

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

FDA Diagnostic Testing Updates

The FDA is working to expedite the delivery of diagnostic testing for COVID-19.
Apr 2020

FDA Addresses Manufacturing Disruptions

Will disruptions in manufacturing result in drug shortages?
Mar 2020

NSAID Use and COVID-19

FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.
Mar 2020
1 2 3 4